本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Adverum Biotechnologies, Inc.

2.70
+0.03001.12%
盘后:2.58-0.1200-4.44%19:41 EDT
成交量:6.30万
成交额:16.93万
市值:5,640.50万
市盈率:-0.37
高:2.75
开:2.69
低:2.61
收:2.67
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
更多
分时
5日
日K
周K
月K
季K
年K
1分
5分
10分
15分
30分
1小时
2小时
2025/06/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/18

重要事件披露

Form 8-K - Current report
2025/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/14

重要事件披露

Form 8-K - Current report
2025/04/15

重要事件披露

Form 8-K - Current report
2025/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/31

重要事件披露

Form 8-K - Current report
2025/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/12/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/04

重要事件披露

Form 8-K - Current report
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/22

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/17

重要事件披露

Form 8-K - Current report
2024/06/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans

如果下载按钮点击无跳转,请点击右上角菜单选择 “在浏览器打开”